BRIDION is indicated for the reversal of neuromuscular blockade induced by rocuronium or vecuronium. In children and adolescents (aged 2-17 years), BRIDION is only recommended for routine reversal of rocuronium-induced neuromuscular blockade*. BRIDION is also indicated for immediate reversal 3 minutes after administration of rocuronium.

The information included on this website is based on the international product information. For country specific details, please refer to the local package insert.

This website is intended for healthcare professionals outside the United States only.

* Moderate (reappearance of second twitch [T2]) or deep (1-2 posttetanic counts [PTCs]) neuromuscular blockade. Data on file, Schering-Plough.